ISEE — IVERIC bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge Cap

Annual balance sheet for IVERIC bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	131	126	210	382	647
Net Total Receivables	0	0.882	1.76	0	—
Prepaid Expenses
Total Current Assets	133	129	217	387	663
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.335	0.669	0.146	1.87	2.13
Long Term Notes Receivable
Other Long Term Assets
Total Assets	137	130	217	389	667
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	13.2	13	25.1	28.2	35.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	13.2	13	25.2	28.8	132
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	124	117	192	361	535
Total Liabilities & Shareholders' Equity	137	130	217	389	667
Total Common Shares Outstanding